Loading clinical trials...
Loading clinical trials...
Phase I Clinical Trial to Assess the Safety and Pharmacokinetic Profile of CKD-581 in Patients With Lymphoma or Multiple Myeloma Failed to Standard Therapy
Conditions
Interventions
CKD-581
Locations
1
South Korea
ASAN Medical Center
Seoul, South Korea
Start Date
May 1, 2012
Primary Completion Date
March 1, 2016
Completion Date
June 1, 2016
Last Updated
October 6, 2016
NCT06179888
NCT05139017
NCT06263491
NCT07388563
NCT06337318
NCT05529069
Lead Sponsor
Chong Kun Dang Pharmaceutical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions